EQS-News

Asklepios Group: Positive business performance in first quarter – Confident outlook for 2024

EQS-News: Asklepios Kliniken / Key word(s): Quarterly / Interim Statement/Quarter Results Asklepios Group: Positive business performance in first quarter – Confident outlook for 2024 23.05.2024 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Asklepios Group: Positive business performance in first quarter – Confident outlook for 2024

• Consolidated revenue up year-on-year at EUR 1,414.5 million
• Consolidated net income (EAT) of EUR 18.5 million
• Increase in patient and employee numbers

Hamburg, 23 May 2024. Asklepios Kliniken GmbH & Co. KGaA has enjoyed a solid economic performance in the first three months of the 2024 financial year. The Asklepios Group can report a positive development despite the ongoing uncertainty in the healthcare sector and global economic challenges.

Asklepios has further consolidated its role as a reliable healthcare partner: 919,532 patients in total were treated in the Asklepios Group’s healthcare facilities in the first three months of the 2024 financial year (3M 2023: 860,826). The number of inpatients was 196,297, 1.9% higher than in the previous year (3M 2023: 192,731), while the number of outpatients rose by 8.3% to 723,235 (3M 2023: 668,095).

Asklepios employed 50,272 full-time equivalents on average in the period from January to March (3M 2023: 49,393). This increase is as a result of strategic recruitment activities and the successful hiring of skilled workers from Germany and abroad.

Revenue increased by 5.4% year-on-year to EUR 1,414.5 million in the first quarter of 2024 (3M 2023: EUR 1,341.8 million). Staff costs rose by EUR 49.6 million as against the same period of the previous year to EUR 974.5 million as a result of pay increases and the growth in headcount. The staff costs ratio matched the previous year’s level at 68.9% (3M 2023: 68.9%). Consolidated net income (EAT) grew to EUR 18.5 million (3M 2023: EUR 9.2 million).